clinically meaningful differences

Related by string. * Clinically : patented clinically proven . clinically localized prostate . clinically obese / MEANINGFUL . Meaningful : demonstrated clinically meaningful . clinically meaningful improvement . clinically meaningful improvements / diff erence . DIFFERENCE . DIFFERENCES : Make Difference Day . DIFFERENCES INCLUDE BUT ARE . citing irreconcilable differences * *

Related by context. Frequent words. (Click for all words.) 66 statistically significant differences 64 dose limiting toxicities 62 laboratory abnormalities 62 QT prolongation 61 seliciclib 61 discontinuations due 61 thromboembolic events 61 noninferiority 61 active comparator 60 FOLFIRI 60 clinically relevant 60 lipid lowering drugs 60 hypercalcemia 60 tocilizumab 60 limiting toxicity 60 placebo controlled trials 59 decitabine 59 Adverse events 59 hepatotoxicity 59 antihypertensive drugs 59 #ME# 59 cardiac toxicity 59 Erlotinib 59 montelukast 59 interferon alfa 59 dacarbazine 59 administered subcutaneously 59 fondaparinux 59 secondary efficacy endpoints 58 nilotinib 58 insulin glargine 58 events SAEs 58 6R BH4 58 Pharmacokinetic 58 vandetanib 58 neoadjuvant 58 subgroup analyzes 58 sunitinib 58 prespecified 58 anakinra 58 Secondary endpoints 58 TORISEL 58 HGS ETR1 58 histologic 58 carvedilol 58 etanercept 58 mg kg dose 58 azacitidine 58 genotoxic 58 LY# [003] 58 nab paclitaxel 57 entecavir 57 clinically meaningful 57 imatinib 57 thrombotic events 57 antiepileptic drug 57 abciximab 57 xenograft models 57 evaluable 57 REMICADE ® 57 placebo controlled studies 57 CA4P 57 statistically significant 57 enalapril 57 myocardial infarctions 57 Combination therapy 57 virologic failure 57 abatacept 57 cytogenetic response 57 esomeprazole 57 Mylotarg 57 thromboembolism 57 angioedema 56 anti TNF 56 mitoxantrone 56 lamotrigine 56 adalimumab 56 Taxotere ® 56 pharmacodynamic 56 pioglitazone 56 AVE# 56 abacavir 56 cardiotoxicity 56 topotecan 56 efficacy endpoints 56 dose regimens 56 cytotoxicity 56 NRTIs 56 RCTs 56 darinaparsin 56 composite endpoint 56 GEMZAR 56 PXD# 56 OXi# 56 FOLFOX 56 hypersensitivity reactions 56 neutralizing antibody 56 temsirolimus 56 TELCYTA 56 pravastatin 56 orally bioavailable

Back to home page